References
1. Hayward JN, Boshell BR. Paraldehyde intoxication with metabolic acidosis: report of two cases, experimental data and a critical review of the literature. Am J Med 1957;23(6):965–76.
2. Sainsbury H. Paraldehyde as a hypnotic [abstract of: Bumke. Monats f Psych u Neur. Dec 1902]. J Ment Sci 1903;49(206):552–4.
3. López-Muñoz F, Shen WW, D’Ocon P, Romero A, Álamo C. A history of the pharmacological treatment of bipolar disorder. Int J Mol Sci 2018;19(7):214.
4. Every-Palmer S, Sutherland O. Abuses in psychiatric care: The shameful story of the Lake Alice Child and Adolescent unit in Aotearoa New Zealand. Aust N Z J Psychiatry 2023;57(9):1193–7.
5. Bodansky M, Jinkins JL, Levine H, Gilbert AJ. Clinical and experimental studies on paraldehyde. Anesthesiology 1941;2(1):20–7.
6. Holden TJ, Cavanagh WG. Use of paraldehyde. Br J Psychiatry 1987;150(4):564–5.
7. Thompson WL, Johnson AD, Maddrey WL, Osler Medical Housestaff. Diazepam and paraldehyde for treatment of severe delirium tremens: a controlled trial. Ann Intern Med 1975;82(2):175–80.
8. Phebra Pty Ltd. Paraldehyde Injection BP: Australian product information. Lane Cove West (NSW): Phebra Pty Ltd. 2015.
9. Johnson CE, Vigoreaux JA. Compatibility of paraldehyde with plastic syringes and needle hubs. Am J Hosp Pharm 1984;41(2):306–8.
10. Burstein CL. The hazard of paraldehyde administration: clinical and laboratory studies. JAMA 1943;121(3):187–90.
